分子生物学用酵素・キット・試薬の世界市場予測(~2022年):PCR、シーケンシング、クローニング、エピジェネティクス

◆英語タイトル:Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning, Epigenetics), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers), and Region - Global Forecast to 2022
◆発行会社/調査会社:MarketsandMarkets
◆商品コード:MAM-BT-2612
◆発行日:2017年10月10日
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆ページ数:176
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (同一法人内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[分子生物学用酵素・キット・試薬の世界市場予測(~2022年):PCR、シーケンシング、クローニング、エピジェネティクス]についてメールでお問い合わせはこちら
MarketsandMarketsが発行した当調査レポートでは、分子生物学用酵素・キット・試薬の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、需要先別分析、地域別分析、分子生物学用酵素・キット・試薬の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
*** レポート概要(サマリー)***

The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 Billion by 2022 from USD 6.52 Billion in 2017, at a CAGR of 15.8% during the forecast period. The growth of this market is majorly driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases & genetic disorders.
The molecular biology enzymes and kits & reagents market is segmented on the basis of product, application, end user, and region. On the basis of product, the global market is segmented into enzymes and kits & reagents. The enzymes market is further subsegmented into polymerases, ligases, restriction endonucleases, reverse transcriptases, phosphatases, proteases & proteinases, and other enzymes (T4 polynucleotide kinases, exonuclease III, methyltransferases, glycosylases, and agarase). The kits & reagents segment is expected to account for the largest share and register the highest CAGR during the forecast period. This can be primarily attributed to the requirement of repeat purchase of these single-use products and increasing drug research in the pharmaceutical industry.

Based on application, the market is segmented into polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection). The sequencing segment is expected to grow at the highest rate during the forecast period primarily due to the increasing DNA sequencing with growth in genomic research, rapid technological advancements, decreasing costs of sequencing, and growing use of whole-genome sequencing and personalized genome sequencing. In 2017, the PCR segment is expected to hold the largest share owing to high demand for PCR equipment by a majority of end users.

Based on end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers, and other end users (contract research organizations, food & beverage companies, and forensic agencies). The hospitals & diagnostic centers segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing adoption of molecular diagnostics and the rising prevalence of disorders that require molecular biology assays (that use kits) for diagnosis.

The geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the increasing research funding for genomics research, rising number of pharmaceutical and biotechnology companies, increasing prevalence of conditions involving molecular diagnostics, and rising investments in research projects in Canada.

The limited reimbursements for genetic testing is expected to restrain the growth of this market during the forecast period.

The major players in this market include Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US).

*** レポート目次(コンテンツ)***

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Research Design
2.2 Research Approach
2.2.1 Secondary Research
2.2.1.1 Secondary Sources
2.2.2 Primary Research
2.2.2.1 Primary Sources
2.3 Market Size Estimation
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 29)

4 Premium Insights (Page No. – 33)
4.1 Molecular Biology Enzymes and Kits & Reagents: Market Overview
4.2 Molecular Biology Enzymes and Kits & Reagents in Asia Pacific Market, By Application and Country, 2017
4.3 Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2017 vs 2022
4.4 Geographic Snapshot of the Molecular Biology Enzymes and Kits & Reagents Market

5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Drivers
5.2.1 Increased Research Activities and R&D Investments in the Life Science Industry
5.2.2 Growing Number of Genome Projects
5.2.3 Technological Advancements in the Life Science Industry
5.2.4 Rising Incidence of Infectious Diseases and Genetic Disorders
5.3 Restraints
5.3.1 Limited Reimbursements for Genetic Testing
5.4 Opportunities
5.4.1 Increased Use of Personalized Medicine
5.4.2 Developing Countries Offer Significant Opportunities for the Market
5.5 Challenges
5.5.1 Privacy Issues Related to Genetic Information

6 Molecular Biology Enzymes and Kits & Reagents Market, By Product (Page No. – 43)
6.1 Introduction
6.2 Kits & Reagents
6.3 Enzymes
6.3.1 Polymerases
6.3.2 Ligases
6.3.3 Restriction Endonucleases
6.3.4 Reverse Transcriptases
6.3.5 Phosphatases
6.3.6 Proteases and Proteinases
6.3.7 Other Enzymes

7 Molecular Biology Enzymes and Kits & Reagents Market, By Application (Page No. – 51)
7.1 Introduction
7.2 Polymerase Chain Reaction
7.3 Sequencing
7.4 Cloning
7.5 Epigenetics
7.6 Restriction Digestion
7.7 Synthetic Biology
7.8 Other Applications

8 Molecular Biology Enzymes and Kits & Reagents Market, By End User (Page No. – 60)
8.1 Introduction
8.2 Academic & Research Institutes
8.3 Pharmaceutical & Biotechnology Companies
8.4 Hospitals & Diagnostic Centers
8.5 Other End Users

9 Molecular Biology Enzymes and Kits & Reagents Market, By Region (Page No. – 67)
9.1 Introduction
9.2 North America
9.2.1 Us
9.2.1.1 Increasing Funding for Genomics Research
9.2.1.2 Growth in the Number of Pharmaceutical and Biotechnology Companies
9.2.1.3 Favorable Reimbursement Scenario for Molecular Diagnostics and Growing Prevalence of Target Indications in the US
9.2.2 Canada
9.2.2.1 Investments in Research Projects
9.3 Europe
9.3.1 Germany
9.3.1.1 Presence of A Large Number of Academic and Research Institutes
9.3.1.2 Increasing Pharmaceutical R&D
9.3.1.3 Venture Capital Investments in Germany
9.3.2 Uk
9.3.2.1 Funding for Research Activities
9.3.2.2 Increasing Adoption of Molecular Diagnostics for Cancer Diagnosis in the Uk
9.3.2.3 The 100,000 Genomes Project
9.3.3 France
9.3.3.1 Presence of A Large Cancer Patient Population
9.3.3.2 Genomic Medicine 2025 Plan
9.3.4 RoE
9.3.4.1 Large Biotechnology and Pharmaceutical Industry in Italy
9.3.4.2 Growth in the Spanish Biotechnology Industry
9.4 Asia Pacific
9.4.1 China
9.4.1.1 Increasing Government Interest in Biomedical and Biotechnology Industries
9.4.1.2 Outsourcing of Clinical Research Activities to China
9.4.2 Japan
9.4.2.1 Involvement of Industry Players in the Japanese Market
9.4.2.2 Focus on Cancer Research and Treatment
9.4.3 India
9.4.3.1 Growing Pharmaceutical Industry in India, Government Initiatives
9.4.3.2 Development of Bio-Clusters to Propel the Biotechnology Industry in India
9.4.4 RoAPAC
9.4.4.1 The Genome Asia 100k Initiative
9.4.4.2 Alliances and Partnerships in Molecular Biology Applications to Boost the Australian Market
9.5 Rest of the World (RoW)
9.5.1 Investments in Research & Innovation Centers and Conferences & Workshops in Brazil
9.5.2 Rising Prevalence of Conditions Involving Molecular Diagnostics in Africa

10 Competitive Landscape (Page No. – 113)
10.1 Introduction
10.2 Market Share Analysis, 2016

11 Company Profiles (Page No. – 115)
(Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments)*
11.1 Thermo Fisher Scientific, Inc.
11.2 Merck KGaA
11.3 Promega Corporation
11.4 New England Biolabs
11.5 Illumina, Inc.
11.6 Takara Bio, Inc.
11.7 Qiagen N.V.
11.8 Agilent Technologies, Inc.
11.9 F. Hoffmann-La Roche Ltd
11.10 Bio Basic Inc.
11.11 Jena Bioscience GmbH
11.12 Molecular Biology Resources, Inc.

*Details on Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 166)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables (88 Tables)

Table 1 Government Funding for Personalized Medicine
Table 2 Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 3 Molecular Biology Kits & Reagents Market, By Region, 2015–2022 (USD Million)
Table 4 Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 5 Molecular Biology Enzymes Market, By Region, 2015–2022 (USD Million)
Table 6 Molecular Biology Enzymes Market for Polymerases, By Region, 2015–2022 (USD Million)
Table 7 Molecular Biology Enzymes Market for Ligases, By Region, 2015–2022 (USD Million)
Table 8 Molecular Biology Enzymes Market for Restriction Endonucleases, By Region, 2015–2022 (USD Million)
Table 9 Molecular Biology Enzymes Market for Reverse Transcriptases, By Region, 2015–2022 (USD Million)
Table 10 Molecular Biology Enzymes Market for Phosphatases, By Region, 2015–2022 (USD Million)
Table 11 Molecular Biology Enzymes Market for Proteases and Proteinases, By Region, 2015–2022 (USD Million)
Table 12 Molecular Biology Enzymes Market for Other Enzymes, By Region, 2015–2022 (USD Million)
Table 13 Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 14 Molecular Biology Enzymes and Kits & Reagents Market for PCR, By Region, 2015–2022 (USD Million)
Table 15 Molecular Biology Enzymes and Kits & Reagents Market for Sequencing, By Region, 2015–2022 (USD Million)
Table 16 Molecular Biology Enzymes and Kits & Reagents Market for Cloning, By Region, 2015–2022 (USD Million)
Table 17 Molecular Biology Enzymes and Kits & Reagents Market for Epigenetics, By Region, 2015–2022 (USD Million)
Table 18 Molecular Biology Enzymes and Kits & Reagents Market for Restriction Digestion, By Region, 2015–2022 (USD Million)
Table 19 Molecular Biology Enzymes and Kits & Reagents Market for Synthetic Biology, By Region, 2015–2022 (USD Million)
Table 20 Molecular Biology Enzymes and Kits & Reagents Market for Other Applications, By Region, 2015–2022 (USD Million)
Table 21 Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 22 Academic & Research Institutes Market, By Region, 2015–2022 (USD Million)
Table 23 Pharmaceutical & Biotechnology Companies Market, By Region, 2015–2022 (USD Million)
Table 24 Hospitals & Diagnostic Centers Market, By Region, 2015–2022 (USD Million)
Table 25 Other End Users Market, By Region, 2015–2022 (USD Million)
Table 26 North America: Molecular Biology Enzymes and Kits & Reagents Market, By Country, 2015–2022 (USD Million)
Table 27 North America: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 28 North America: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 29 North America: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 30 North America: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 31 Funding for Genomics-Related Projects
Table 32 US: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 33 US: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 34 US: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 35 US: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 36 Canada: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 37 Canada: Enzymes Market, By Type, 2015-2022 (USD Million)
Table 38 Canada: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 39 Canada: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 40 Europe: Molecular Biology Enzymes and Kits & Reagents Market, By Country, 2015–2022 (USD Million)
Table 41 Europe: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 42 Europe: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 43 Europe: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 44 Europe: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 45 Germany: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 46 Germany: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 47 Germany: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 48 Germany: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 49 UK: Number of Molecular Diagnostic Tests Conducted Between 2011 and 2014, By Cancer Type
Table 50 UK: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 51 UK: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 52 UK: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 53 UK: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 54 France: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 55 France: Enzymes Market, By Type, 2015–2022 (USD Million)
Table 56 France: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 57 France: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 58 RoE: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 59 RoE: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 60 RoE: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 61 RoE: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 62 APAC: Molecular Biology Enzymes and Kits & Reagents Market, By Country, 2015–2022 (USD Million)
Table 63 APAC: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 64 APAC: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 65 APAC: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 66 APAC: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 67 China: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 68 China: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 69 China: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 70 China: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 71 Japan: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 72 Japan: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 73 Japan: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 74 Japan: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 75 India: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 76 India: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 77 India: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 78 India: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 79 RoAPAC: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 80 RoAPAC: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 81 RoAPAC: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 82 RoAPAC: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)
Table 83 Hiv Infections and Aids-Related Deaths in the Middle East and Africa, 2015
Table 84 RoW: Molecular Biology Enzymes and Kits & Reagents Market, By Region, 2015–2022 (USD Million)
Table 85 RoW: Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2015–2022 (USD Million)
Table 86 RoW: Molecular Biology Enzymes Market, By Type, 2015–2022 (USD Million)
Table 87 RoW: Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2015–2022 (USD Million)
Table 88 RoW: Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2015–2022 (USD Million)

List of Figures (33 Figures)

Figure 1 Research Design: Global Molecular Biology Enzymes and Kits & Reagents Market
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Key Industry Insights
Figure 5 Bottom-Up Approach
Figure 6 Top-Down Approach
Figure 7 Data Triangulation
Figure 8 Molecular Biology Enzymes and Kits & Reagents Market, By Product, 2017
Figure 9 Molecular Biology Enzymes and Kits & Reagents Market, By Application, 2017 vs 2022
Figure 10 Molecular Biology Enzymes and Kits & Reagents Market, By End User, 2017 vs 2022
Figure 11 Geographic Snapshot of the Molecular Biology Enzymes and Kits & Reagents Market
Figure 12 Increase in Research Activities in the Life Science Industry is A Key Growth Driver of the Market
Figure 13 Academic & Research Institutes Segment to Dominate the Asia Pacific Molecular Biology Enzymes and Kits & Reagents Market in 2017
Figure 14 PCR Will Continue to Dominate the Molecular Biology Enzymes and Kits & Reagents Market in 2022
Figure 15 Asia Pacific to Register the Highest CAGR During the Forecast Period
Figure 16 Molecular Biology Enzymes and Kits & Reagents Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Kits & Reagents Segment to Dominate the Market in 2017
Figure 18 The PCR Application Segment to Dominate the Market in 2017
Figure 19 Academic & Research Institutes to Dominate the Market in 2017
Figure 20 North America Estimated to Be the Largest Regional Market for Molecular Biology Enzymes and Kits & Reagents in 2017
Figure 21 North American Molecular Biology Enzymes and Kits & Reagents Market Snapshot
Figure 22 Number of New Pharmaceutical and Biotechnology Companies in the Us, 2014–2016
Figure 23 European Molecular Biology Enzymes and Kits & Reagents Market Snapshot
Figure 24 APAC Molecular Biology Enzymes and Kits & Reagents Market Snapshot
Figure 25 RoW: Molecular Biology Enzymes and Kits & Reagents Market Snapshot
Figure 26 Global Molecular Biology Enzymes and Kits & Reagents Market Share Analysis, By Key Player, 2016
Figure 27 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 28 Merck KGaA: Company Snapshot
Figure 29 Illumina, Inc.: Company Snapshot
Figure 30 Takara Bio, Inc.: Company Snapshot
Figure 31 Qiagen N.V.: Company Snapshot
Figure 32 Agilent Technologies, Inc.: Company Snapshot
Figure 33 F. Hoffmann-La Roche Ltd: Company Snapshot



*** レポートのキーワード ***

分子生物学、酵素、キット、試薬、PCR、シーケンシング、クローニング、エピジェネティクス

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MAM-BT-2612 )"分子生物学用酵素・キット・試薬の世界市場予測(~2022年):PCR、シーケンシング、クローニング、エピジェネティクス" (英文:Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning, Epigenetics), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers), and Region - Global Forecast to 2022)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。